| __timestamp | Arrowhead Pharmaceuticals, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 72429000 |
| Thursday, January 1, 2015 | 34718089 | 78634000 |
| Friday, January 1, 2016 | 40998209 | 75374000 |
| Sunday, January 1, 2017 | 32022880 | 92157000 |
| Monday, January 1, 2018 | 19110051 | 93326000 |
| Tuesday, January 1, 2019 | 26556257 | 103132000 |
| Wednesday, January 1, 2020 | 52275890 | 110171000 |
| Friday, January 1, 2021 | 80981000 | 218817000 |
| Saturday, January 1, 2022 | 124431000 | 233827000 |
| Sunday, January 1, 2023 | 90932000 | 267194000 |
| Monday, January 1, 2024 | 98761000 |
Cracking the code
In the ever-evolving landscape of the pharmaceutical industry, understanding the financial dynamics of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Lantheus Holdings, Inc. and Arrowhead Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Lantheus Holdings consistently outpaced Arrowhead Pharmaceuticals in SG&A spending, with a peak in 2023 where their expenses were approximately 2.7 times higher than Arrowhead's. Notably, Lantheus saw a significant increase in 2021, with expenses surging by 98% compared to 2020. Meanwhile, Arrowhead's SG&A costs showed a steady upward trend, peaking in 2022. The data highlights the strategic financial decisions made by these companies, reflecting their growth trajectories and market strategies. Missing data for 2024 suggests a need for further updates to maintain comprehensive insights.
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Arrowhead Pharmaceuticals, Inc.
Viatris Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Insmed Incorporated vs Lantheus Holdings, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Exelixis, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Blueprint Medicines Corporation or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs Geron Corporation
SG&A Efficiency Analysis: Comparing Lantheus Holdings, Inc. and MiMedx Group, Inc.
Breaking Down SG&A Expenses: Lantheus Holdings, Inc. vs Evotec SE
Cost Management Insights: SG&A Expenses for Grifols, S.A. and Arrowhead Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Corcept Therapeutics Incorporated vs Arrowhead Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of HUTCHMED (China) Limited and Arrowhead Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Arrowhead Pharmaceuticals, Inc. and MannKind Corporation